Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers .1. Inhalation characteristics, work of breathing and volunteers' preference in dependence of the inhaler resistance

被引:48
作者
deBoer, AH
Winter, HMI
Lerk, CF
机构
[1] Groningen Inst. Drug Studs. (GIDS), Dept. Pharmaceutical Technol. B., University of Groningen, 9713 AV Groningen
关键词
asthma; dry powder inhalers; peak inspiratory flow rate; preferable inhaler resistance; work of breathing; inspiration mode; inspiration force;
D O I
10.1016/0378-5173(95)04326-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A test inhaler with exchangeable air flow resistances encompassing the range of commercial DPIs has been used to study the inspiratory flow curves of 39 healthy adult volunteers. A strong increase in mean Peak Inspiratory Flow Rate (PIFR) has been obtained with decreasing inhaler resistance, varying between 160 l/min for a resistance equivalent to the Rotahaler and 50 l/min for the simulated Inhalator Ingelheim at maximum inspiratory effort. The volunteers experienced on average 55% of maximum effort as comfortable (expressed in PIFR) and gave preference (82%) to relative high air flow resistances in the range of 0.4-0.9 x 10(5)(N-0.5. S . m(-4)). It has been calculated that the real amount of work of breathing does not increase with increasing air flow resistance at comfortable inspiration mode. At maximum inspiration, the amount of work performed through a high resistance inhaler (1.5 x 10(5)) is approx. 70% of that through a low resistance device (0.4 x 10(5)). The calculated mean PIFR of 62 l/min at maximum effort through an air flow resistance of 0.9 x 10(5), equivalent to the Turbuhaler, is in good agreement with PIFR-values of 68.5 vs. 59 l/min from two other studies with asthmatic patients through this device. It has, therefore, been concluded that the flow curves of healthy volunteers may be used to predict the range of PIFRs for asthmatics through the same air flow resistances.
引用
收藏
页码:231 / 244
页数:14
相关论文
共 15 条
[1]  
ANDERSEN PB, 1993, EUR RESPIR J S, V6, P148
[2]   PULMONARY DEPOSITION OF INHALED TERBUTALINE - COMPARISON OF SCANNING GAMMA-CAMERA AND URINARY-EXCRETION METHODS [J].
BORGSTROM, L ;
NEWMAN, S ;
WEISZ, A ;
MOREN, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (08) :753-755
[3]  
BROWN PH, 1991, EUR RESPIR J S, V14, pS518
[4]  
CLARK AR, 1992, J AEROSOL MED, V6, P99
[5]  
ENGEL T, 1990, EUR RESPIR J, V3, P1037
[6]  
KIRK WF, 1986, PHARM INT, P150
[7]   DOSAGE FORMS AND FORMULATIONS FOR DRUG ADMINISTRATION TO THE RESPIRATORY-TRACT [J].
MOREN, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (4-5) :695-728
[8]   NEW REGRESSION EQUATIONS FOR PREDICTING PEAK EXPIRATORY FLOW IN ADULTS [J].
NUNN, AJ ;
GREGG, I .
BRITISH MEDICAL JOURNAL, 1989, 298 (6680) :1068-1070
[9]   A MODEL FOR THE EFFECT OF INHALATION DEVICE FLOW RESISTANCE ON THE PEAK INSPIRATORY FLOW-RATE AND ITS APPLICATION IN PHARMACEUTICAL TESTING [J].
OLSSON, B ;
ASKING, L .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1994, 7 (02) :201-204
[10]  
OLSSON B, 1994, J AEROSOL MED S, V7, P43